* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Tuesday, August 5, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    ‘Billie Jean’ – Hyde Park Herald

    The Enduring Magic Behind ‘Billie Jean’ Revealed

    Hank Hill returns to a changed world in new ‘King of the Hill’ episodes – New Haven Register

    Hank Hill Navigates a Bold New World in Thrilling New ‘King of the Hill’ Episodes

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Go-to entertainment: why gaming was made for the toilet – The Guardian

    Why Gaming Is the Ultimate Way to Pass Time in the Bathroom

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Nasdaq-listed Verb Technology to build $558 million TON treasury, rebrand as TON Strategy Co. – The Block

    Nasdaq-Listed Verb Technology to Build $558 Million TON Treasury and Rebrand as TON Strategy Co

    How Tech Firms Like Google and Meta Are Embracing the Military – The New York Times

    How Tech Firms Like Google and Meta Are Embracing the Military – The New York Times

    Credo Technology: Wiring The AI Revolution (NASDAQ:CRDO) – Seeking Alpha

    Credo Technology: Driving the Next Wave of AI Innovation

    Microsoft Seeks to Extend Access to OpenAI Technology – PYMNTS.com

    Microsoft Aims to Broaden Access to OpenAI Technology

    Livonia police use grappler technology to stop drunk driver – ClickOnDetroit | WDIV Local 4

    Livonia Police Deploy Grappler Technology to Safely Stop Drunk Driver

    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    ‘Billie Jean’ – Hyde Park Herald

    The Enduring Magic Behind ‘Billie Jean’ Revealed

    Hank Hill returns to a changed world in new ‘King of the Hill’ episodes – New Haven Register

    Hank Hill Navigates a Bold New World in Thrilling New ‘King of the Hill’ Episodes

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Go-to entertainment: why gaming was made for the toilet – The Guardian

    Why Gaming Is the Ultimate Way to Pass Time in the Bathroom

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Nasdaq-listed Verb Technology to build $558 million TON treasury, rebrand as TON Strategy Co. – The Block

    Nasdaq-Listed Verb Technology to Build $558 Million TON Treasury and Rebrand as TON Strategy Co

    How Tech Firms Like Google and Meta Are Embracing the Military – The New York Times

    How Tech Firms Like Google and Meta Are Embracing the Military – The New York Times

    Credo Technology: Wiring The AI Revolution (NASDAQ:CRDO) – Seeking Alpha

    Credo Technology: Driving the Next Wave of AI Innovation

    Microsoft Seeks to Extend Access to OpenAI Technology – PYMNTS.com

    Microsoft Aims to Broaden Access to OpenAI Technology

    Livonia police use grappler technology to stop drunk driver – ClickOnDetroit | WDIV Local 4

    Livonia Police Deploy Grappler Technology to Safely Stop Drunk Driver

    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease

November 5, 2023
in Health
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease
Share on FacebookShare on Twitter

PHILADELPHIA — A low-dose, investigational endothelin A receptor antagonist paired with an SGLT2 inhibitor reduced albuminuria in patients with chronic kidney disease (CKD) in the phase IIb ZENITH-CKD trial.

By week 12 of treatment, patients on zibotentan 1.5 mg plus dapagliflozin had a -33.7% (90% CI -42.5 to -23.5) difference in urinary albumin-to-creatinine ratio (UACR) compared with dapagliflozin (Farxiga) added onto placebo, reported Hiddo Heerspink, PhD, of the University Medical Center Groningen in the Netherlands, at the American Society of Nephrology (ASN) Kidney Week.

An even lower dose of zibotentan — 0.25 mg — was also effective at reducing albuminuria, as patients on this dose plus dapagliflozin saw a -27.0% (90% CI -38.4 to -13.6) difference in UACR compared with dapagliflozin alone, according to the trial that was simultaneously published in The Lancet.

“Zibotentan in combination with dapagliflozin reduced albuminuria more than dapagliflozin alone and this effect was apparent already after 3 weeks of treatment and was sustained over time,” Heerspink said in the ASN presentation. “During the [2-week] washout period, we see that albuminuria returned to baseline.”

The trial was originally designed as part A and part B. Participants randomized in part A were slated to receive a higher dose of zibotentan, with one group only receiving 5 mg of zibotentan and another receiving 5 mg plus dapagliflozin 10 mg/day. However, this part of the trial was stopped during due to increased rates of fluid retention.

After that, Heerspink’s group only continued with part B of the trial: zibotentan 1.5 mg plus dapagliflozin 10 mg/day and zibotentan 0.25 mg plus dapagliflozin 10 mg/day.

Here, fluid-retention events were observed in 18% (33/179) of participants in the zibotentan 1.5-mg group, 9% (8/91) of the zibotentan 0.25-mg group, and 18% (14/177) of the dapagliflozin plus placebo group. This was defined as an increase in body weight of at least 3% — at least 2.5% must have been from total body water — from baseline or an increase of at least 100% in B-type natriuretic peptide (BNP) and either a BNP concentration greater than 200 pg/mL, if without atrial fibrillation, or BNP greater than 400 pg/mL if with atrial fibrillation.

The researchers described zibotentan as “the most potent and selective endothelin A receptor antagonist developed to date.” But endothelin A receptor antagonists (ERAs) cause fluid retention and edema, so it was paired with an SGLT2 inhibitor, which has both diuretic effects and renoprotective properties. Other ERAs in development or on the market today include atrasentan and sparsentan.

“The fluid retention profile of a low-dose combination supports further clinical trials,” Heerspink added. “Results of these larger and longer studies in a high-risk CKD populations are awaited.”

In an accompanying comment in The Lancet, Neeraj Dhaun, MBChB, PhD, and Gavin Brian Chapman , both of the University of Edinburgh, called the low rates of fluid retention with these lower zibotentan doses “encouraging.” However, they also pointed out that “caution is needed when interpreting this finding,” given the disproportionate number of patients with heart failure at baseline across the three groups: 10% with dapagliflozin monotherapy, 3% with low-dose zibotentan and dapagliflozin, and 6% with high-dose zibotentan and dapagliflozin.

“Additionally, participants with an increased circulating [BNP] concentration — an indirect marker of left ventricular stretch — and, therefore, those most likely to develop fluid overload with endothelin antagonists, were excluded from the study,” they added.

BNP increase, fluid retention, peripheral edema, and hypotension were the most common adverse events (AEs) leading to drug discontinuation, but occurred in less than 3% of participants. Rates of other AEs were generally low, including headache (≤5% on zibotentan), metabolic acidosis (≤4%), BNP increase (≤5%), and hypertension (≤5%).

This 170-site trial was conducted across 18 countries with adults with an eGFR of 20 mL/min per 1.73 m² or more and a UACR of 150-5000 mg/g. All patients were already on maximally tolerated RAAS inhibition. The average age of patients was around 62, 69% were male, and 62%-71% were white. Baseline eGFR was 46.7 mL/min per 1.73 m² and median UACR was 565.6 mg/g.

Throughout the trial, all groups also saw a significant drop from baseline in systolic blood pressure, one of the secondary efficacy endpoints. Heerspink pointed out that this decline in systolic blood pressure was not correlated to the change in UACR:

Zibotentan/dapagliflozin 0.25 mg/10 mg: -7.1 mmHg (90% CI -10.0 to -4.1)Zibotentan/dapagliflozin 1.5 mg/10 mg: -11.0 (mmHg 90% CI -13.5 to -8.4)Dapagliflozin 10 mg: -3.4 mmHg (90% CI -5.8 to -1.0)

The secondary endpoint of change in eGFR took a dive within the first week of treatment, and didn’t rebound to baseline levels until the washout period:

Zibo/dapa 0.25 mg/10 mg: -3.1 (90% CI -4.7 to -1.5)Zibo/dapa 1.5 mg/10 mg: -3.0 (90% CI -4.4 to -1.6)Dapa 10 mg: -1.9 (90% CI -3.3 to -0.6)

The researchers reported that all groups saw a significant drop in average body weight, with the dapagliflozin-only group seeing the biggest drop. BNP numerically increased in all groups, but was only significant in the zibotentan 1.5-mg group.

Heerspink said his group started work on the phase III ZENITH High Proteinuria outcome trial, which will include patients with an eGFR between 20 to 90 mL/min per 1.73 m² and UACR above 700 mg/g or a urine protein creatinine ratio above 1,000 mg/g.

Disclosures

The trial was funded by AstraZeneca. Some co-authors are company employees.

Heerspink disclosed relationships with AstraZeneca, Boehringer Ingelheim, Janssen, Novo Nordisk, Bayer, Chinook, CSL Behring, Dimerix, Eli-Lilly, Gilead, Janssen, Novartis, and Travere Therapeutics. Co-authors disclosed multiple relationships with industry.

Dhaun reported a relationship with Travere Therapeutics. Chapman disclosed no relationships with industry.

Primary Source

The Lancet

Source Reference: Heerspink HJL, et al “Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial” Lancet 2023; DOI: 10.1016/ S0140-6736(23)02230-4.

Secondary Source

The Lancet

Source Reference: Dhaun N and Chapman GB “Endothelin antagonism: stepping into the spotlight” Lancet 2023; DOI: 10.1016/ S0140-6736(23)02419-4.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/asn/107167

Tags: CombohealthInhibitor
Previous Post

Efgartigimod Offers Hope in Chronic Inflammatory Demyelinating Polyneuropathy

Next Post

Botulinum Toxin Injection May Be an Option for Excess Saliva in Patients With ALS

Your nature photo might be a scientific breakthrough in disguise – ScienceDaily

Your Nature Photo Could Be the Next Big Scientific Discovery

August 5, 2025
Scientists reexamine 47-year-old fossil and discover a new Jurassic sea monster – ScienceDaily

47-Year-Old Fossil Reveals an Astonishing New Jurassic Sea Monster

August 5, 2025
Moment of Science: Parker probe offers insights into sun, solar wind – WIS News 10

Parker Probe Unveils New Secrets About the Sun and Solar Wind

August 5, 2025
Nurse, marathon runner Jin Lee promotes healthy lifestyle by example – Bucks County Herald newspaper

Nurse, marathon runner Jin Lee promotes healthy lifestyle by example – Bucks County Herald newspaper

August 5, 2025
Who’s the top dog? Wave-riding canines compete in the World Dog Surfing Championships – NPR

Meet the Ultimate Wave-Riding Dogs Competing for the World Surfing Championship!

August 5, 2025
‘The Big Short’ investor warns despite economy’s stronghold against ‘thoughtless,’ ‘unprecedented’ tariffs so far, stagflation is coming – Fortune

The Big Short’ Investor Issues Stark Warning: Stagflation Threatens Despite Economy’s Surprising Strength Against Unprecedented Tariffs

August 5, 2025
‘Billie Jean’ – Hyde Park Herald

The Enduring Magic Behind ‘Billie Jean’ Revealed

August 5, 2025
Health insurance in Pennsylvania may see biggest hike in years – 90.5 WESA

Pennsylvania Braces for Its Largest Health Insurance Increase in Years

August 5, 2025
The Origins of the Political Power Grab in Texas – The New York Times

Inside Texas’s Bold Quest for Political Control

August 5, 2025
Nasdaq-listed Verb Technology to build $558 million TON treasury, rebrand as TON Strategy Co. – The Block

Nasdaq-Listed Verb Technology to Build $558 Million TON Treasury and Rebrand as TON Strategy Co

August 5, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (755)
  • Economy (780)
  • Entertainment (21,657)
  • General (16,295)
  • Health (9,817)
  • Lifestyle (788)
  • News (22,149)
  • People (779)
  • Politics (789)
  • Science (15,993)
  • Sports (21,275)
  • Technology (15,757)
  • World (761)

Recent News

Your nature photo might be a scientific breakthrough in disguise – ScienceDaily

Your Nature Photo Could Be the Next Big Scientific Discovery

August 5, 2025
Scientists reexamine 47-year-old fossil and discover a new Jurassic sea monster – ScienceDaily

47-Year-Old Fossil Reveals an Astonishing New Jurassic Sea Monster

August 5, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version